Cargando…
Design, Synthesis and in Vitro Degradation of a Novel Co-Drug for the Treatment of Psoriasis
Psoriasis is a common, chronic and relapsing inflammatory skin disease. It affects approximately 2% of the western population and has no cure. Combination therapy for psoriasis often proves more efficacious and better tolerated than monotherapy with a single drug. Combination therapy could be admini...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834954/ https://www.ncbi.nlm.nih.gov/pubmed/24300448 http://dx.doi.org/10.3390/pharmaceutics5020232 |